[ORGANIZATION]
Sevabertinib
Featured in 1 tracked story · first seen
Situations
Bayer Hyrnuo regulatory approvals for lung cancer
2 clusters · 4 sources · last updated
Latest: Bayer receives US FDA approval for lung cancer drug Hyrnuo
Bayer has secured regulatory approvals for its lung cancer drug, Hyrnuo (sevabertinib), in major international markets. In August 2026, Japan’s Ministry of Health, Labour and Welfare approved the therapy for patients w